thednacompany.com
The DNA Company Named Functional Genomics Innovation of the Year for the 2025 BioTech Breakthrough Awards
Award recognizes The DNA Company’s innovative and groundbreaking achievements in functional genomics for optimizing health and longevity
CORONA, Calif. (Nov. 10, 2025) – The DNA Company, a global leader in functional genomics and personalized health, has been named Functional Genomics Innovation of the Year in the 2025 BioTech Breakthrough Awards. The recognition highlights the company’s pioneering approach to using genomic science to optimize health, longevity and quality of life.
“This award reflects our ongoing commitment to advancing personalized health through the power of functional genomics,” said Tracy Wood, CEO of The DNA Company. “We are passionate about transforming complex genetic data into simple, actionable insights that help people live healthier, longer lives.”
The BioTech Breakthrough Awards honor excellence and innovation in the life sciences and biotechnology industries, recognizing companies, products and research that are driving meaningful progress in health and medical technology. This year’s program received thousands of nominations from leading biotech companies and research institutions across the globe.
The DNA Company was awarded for their efforts in redefining how genetics are applied in everyday life through their DNA 360 Test and comprehensive genomic reports. Unlike traditional genetic testing, The DNA Company’s functional genomics approach examines how genes express in real-world contexts — such as sleep, mood, metabolism and cardiovascular health — to deliver precise, personalized insights.
Winning the Functional Genomics Innovation of the Year award underscores The DNA Company’s leadership in bridging the gap between advanced science and practical health solutions. The company continues to advance research in functional genomics, working toward a future where personalized health is accessible to everyone.
For more information on The BioTech Breakthrough Awards, visit:
BioTech Breakthrough Awards official site
To learn more about The DNA Company, visit:
thednacompany.com
Tracy Wood Featured in MSN’s “Top 20 Women Leading Biohacking & Longevity”
This feature highlights Tracy’s groundbreaking leadership in precision wellness and her mission to make DNA-based, personalized health solutions accessible to everyone. Through her work at The DNA Company, Tracy continues to redefine how individuals understand their biology—empowering them to optimize energy, focus, and long-term health.
As a recognized voice in the wellness community, Tracy’s inclusion in MSN’s global spotlight reinforces our shared commitment to bridging science-backed genomics with compassionate care and real-world transformation.
Read Full Article
Tracy Wood, CPC, ELi-MP, HHA, CFGP
Chief Executive Officer, The DNA Company
Dr. Krista Kostroman Featured in Daily Mail
We’re excited to share that The DNA Company was prominently featured in a new piece from Daily Mail titled, Mystery of ancient DNA marker rewrites story of how humans first reached the Americas. This feature highlights the groundbreaking discovery of Haplogroup X, a genetic marker that challenges long-standing migration theories about how early humans reached the Americas.
Read Daily Mail Article
Dr. Krista Kostroman, ND, BCS, FGP
Chief Science Officer of The DNA Company
Dr. Krista Kostroman, ND, BCS, FGP
Chief Science Officer of The DNA Company
Dr. Krista Kostroman Featured in The Flow Space
Dr. Krista Kostroman, ND, BCS, FGP, Chief Science Officer at The DNA Company, was recently featured in The Flow Space in an article exploring how beauty standards are evolving for breast cancer survivors.
In her interview, Dr. Kostroman sheds light on the vital role of functional genomics in understanding the body’s healing capacity and redefining self-image after medical treatments. She emphasizes that the path to recovery isn’t just physical — it’s deeply personal and rooted in how women reconnect with their bodies after trauma.
Dr. Krista Kostroman Featured in SingleCare
We’re proud to share that Dr. Krista Kostroman, ND, BCS, FGP, Chief Science Officer at The DNA Company,
was recently featured in SingleCare’s article,
“Repatha Savings: How to Get the Best Price on This Cholesterol-Lowering Medication.”
In the piece, Dr. Kostroman provides expert insights into how genetics can influence the body’s response
to cholesterol medications like Repatha. She highlights the importance of personalized medicine in
optimizing treatment outcomes and reducing side effects — a step toward more informed, DNA-based healthcare.
Dr. Krista Kostroman, ND, BCS, FGP
Chief Science Officer of The DNA Company
Dr. Stephanie Nielsen Featured in Parade
We’re thrilled to share that Dr. Stephanie Nielsen, PharmD, CCN, CFGP—pharmacist and functional genomics practitioner at The DNA Company—was recently featured in Parade for her expert insights on nutrient absorption and wellness.
In this article, Dr. Nielsen explained how calcium and magnesium share absorption pathways—using a clever, real-world analogy comparing it to a ride-share system to help readers visualize how these minerals interact within the body.
Dr. Stephanie Nielsen, PharmD, CCN, CFGP
Functional Genomics Practitioner, The DNA Company
Dr. Stephanie Nielsen, PharmD, CCN, CFGP
Functional Genomics Practitioner, The DNA Company
Dr. Stephanie Nielsen Featured in TruMed
In her TruMed feature, Dr. Nielsen shared her expert advice on how vitamins and supplements can qualify for HSA reimbursement when prescribed for specific medical conditions.
She highlighted the importance of professional guidance and proper documentation to ensure accessibility and affordability in health and wellness—aligning with The DNA Company’s mission to make personalized healthcare easier to access for everyone.
